Literature DB >> 19868931

CLASSIFICATION OF THE HEMOLYTTC STREPTOCOCCI BY THE PRECIPITIN REACTION.

C H Hitchcock1.   

Abstract

A method is described for the preparation from hemolytic streptococci of extracts containing a soluble precipitating substance. By the use of such extracts, it is shown that nearly all members of this family yield a common precipitable substance. So far, therefore, as concerns the precipitin reaction, the hemolytic streptococci form a practically homogeneous group.

Year:  1924        PMID： 19868931      PMCID： PMC2128587          DOI： 10.1084/jem.40.4.445

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  6 in total

1.  THE RELATION BETWEEN HEMOLYTIC AND NON-HEMOLYTIC STREPTOCOCCI, AND ITS POSSIBLE SIGNIFICANCE.

Authors:  R A Kinsella
Journal:  J Exp Med       Date:  1918-08-01       Impact factor: 14.307

2.  IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS.

Authors:  O T Avery; M Heidelberger
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

3.  STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  A R Dochez; O T Avery; R C Lancefield
Journal:  J Exp Med       Date:  1919-09-01       Impact factor: 14.307

4.  THE CLASSIFICATION OF HEMOLYTIC STREPTOCOCCI.

Authors:  R A Kinsella; H F Swift
Journal:  J Exp Med       Date:  1918-08-01       Impact factor: 14.307

5.  FURTHER STUDIES ON BACTERIAL HYPERSUSCEPTIBILITY. II.

Authors:  H Zinsser; J T Parker
Journal:  J Exp Med       Date:  1923-01-31       Impact factor: 14.307

6.  STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : II. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS ISOLATED FROM SCARLET FEVER.

Authors:  W P Bliss
Journal:  J Exp Med       Date:  1922-10-31       Impact factor: 14.307
  6 in total
  10 in total

1.  THE IMMUNOLOGICAL RELATIONSHIPS OF STREPTOCOCCUS VIRIDANS AND CERTAIN OF ITS CHEMICAL FRACTIONS : I. SEROLOGICAL REACTIONS OBTAINED WITH ANTIBACTERIAL SERA.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

2.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

3.  STUDIES ON INDIFFERENT STREPTOCOCCI : I. SEPARATION OF A SEROLOGICAL GROUP-TYPE I.

Authors:  C H Hitchcock
Journal:  J Exp Med       Date:  1928-08-31       Impact factor: 14.307

4.  PRECIPITATION AND COMPLEMENT FIXATION REACTIONS WITH RESIDUE ANTIGENS IN THE NON-HEMOLYTIC STREPTOCOCCUS GROUP.

Authors:  C H Hitchcock
Journal:  J Exp Med       Date:  1924-10-31       Impact factor: 14.307

5.  A STUDY OF HEMOLYTIC STREPTOCOCCI IN ACUTE RHEUMATIC FEVER, WITH AN ANALYSIS OF THE ANTIGENIC RELATIONSHIPS EXISTING AMONG CERTAIN STRAINS.

Authors:  C H Andrewes; C L Derick; H F Swift
Journal:  J Exp Med       Date:  1926-01-01       Impact factor: 14.307

6.  Group A streptococcus polysaccharide: studies on its preparation, chemical composition, and cellular localization after intravenous injection into mice.

Authors:  W C SCHMIDT
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

7.  PROTEIN FRACTIONS OF A SCARLATINAL STRAIN OF STREPTOCOCCUS HEMOLYTICUS.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

8.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : II. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE PROTEIN FRACTIONS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-02-29       Impact factor: 14.307

9.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : III. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE SPECIES-SPECIFIC SUBSTANCE.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-02-29       Impact factor: 14.307

10.  A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.